Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The Australian pharmaceutical company Alchemia Limited has appointed Thomas Liquard as chief executive officer following the departure of Charles Walker. Liquard, who joined Alchemia in December 2013 as chief operating officer, brings ...

Andromeda Biotech Ltd. has formed an agreement with Teva Pharmaceutical Industries Ltd. for the acquisition of Teva's rights for Andromeda's drug, DiaPep277®  for the treatment of Type 1 diabetes. According to the agreement, Teva will...

Pfizer and Merck & Co. have agreed to explore the therapeutic potential of Merck's investigational anti-PD-1 therapy, MK-3475, in combination with two Pfizer oncology assets. A Phase I/II clinical study will evaluate the safety and...